Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 26, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Can Lupus & rheumatoid arthritis patients safely get Covid jabs?

Impact of plastic pollution on marine turtles

Are marine invertebrate corals thermally tolerant?

Can Lupus & rheumatoid arthritis patients safely get Covid jabs?
  • BiotechToday
  • World

Can Lupus & rheumatoid arthritis patients safely get Covid jabs?

BioTech Today August 6, 2021August 5, 2021

Soumya Shraddhya Paul, Amity University, Noida

Rheumatoid arthritis patients may be afraid that the COVID-19 vaccination will have negative side effects, aggravating their disease. Some people have even said that they do not believe it is safe for them to get the vaccine. That, however, is not the case. According to specialists, the chances of this happening are extremely low, and it is never deadly. Experts also stated that individuals with certain underlying health issues should get the vaccine first, before others.

Safety of the COVID vaccine:

Patients with rheumatic and musculoskeletal illnesses, such as inflammatory arthritis and lupus, were shown to be safe after two doses of the mRNA Covid-19 vaccine, according to recent research. Flares of these symptoms were rare after two doses. The study looked at 1,377 individuals with rheumatic and musculoskeletal disorders and was published in the journal Arthritis and Rheumatology.

According to specialists, around 11% of individuals experienced flares following immunization that required treatment, although no severe flares were observed. The most famous research took place in Israel, which has one of the highest immunization rates in the world. Researchers presented their findings at the EULAR virtual conference in June 2021, and the article was published in the Annals of the Rheumatic Diseases in May 2021. They discovered that 82 percent of patients with RA (the control group) had a robust immunological response to the vaccinations.

Early safety findings might help people with rheumatic and musculoskeletal diseases overcome their fears of immunisation. The first author of the study in discussion, Caoilfhionn Connolly, of Johns Hopkins University’s School of Medicine, said, “the findings show that the vaccinations are safe and should assuage any patients’ safety worries”.

The COVID Vaccine Well Tolerated By Lupus Patients:

Except for individuals with a documented allergy to a vaccine component or life-threatening illness, the American College of Rheumatology supports COVID immunisation for persons with lupus and other rheumatic illnesses (currently resulting in intensive care).

The Covid vaccination is often well tolerated in patients with lupus, according to recent research published in The Lancet journal. Only 3% of individuals (21 out of 693) experienced a medically verified lupus flare within three days following immunization. This resulted in a change in lupus therapy in the majority of instances (71%), and four of the 21 patients were hospitalized as a result of the flare-up.

Also read: Understanding Epithelial-Mesenchymal Transition

References:

  • Are covid-19 vaccines safe for patients suffering from rheumatic arthritis and lupus disease? | thehealthsite. Com. (2021, August 5). TheHealthSite.
  • Rheumatoid arthritis and covid-19 vaccination: Questions and answers | everyday health. (n.d.). EverydayHealth.Com. Retrieved August 5, 2021, from https://www.everydayhealth.com/rheumatoid-arthritis/things-people-with-rheumatoid-arthritis-must-know-about-the-covid-19-vaccines/
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Author info:

Soumya Shraddhya Paul is an undergrad biotechnology student who worked in building 3D prosthetics in Base Hospital Delhi Cantt, and holds a key interest in nutraceuticals and enzymology.

Publication:

  • https://bioxone.in/news/worldnews/understanding-b-cell-genomics-to-fight-against-covid-19/
  • https://bioxone.in/news/worldnews/the-current-ebola-epidemic-comes-to-an-end/
  • https://bioxone.in/news/worldnews/an-improved-highly-resistant-tuberculosis-treatment-strategy/
  • https://bioxone.in/news/worldnews/exosomes-role-in-lung-cancer-metastasis/
  • https://bioxone.in/news/worldnews/depressive-disorders-and-pharmacotherapy-new-info-revealed/

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged COVID-19 vaccines immunization Lupus mRNA musculoskeletal illnesses rheumatoid arthritis

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Are marine invertebrate corals thermally tolerant?

bioxone August 6, 2021

Monika Raman, PSG College of Technology, Coimbatore Due to increased anthropogenic pressure, coral reefs have suffered significant losses in recent years. Coral bleaching, or the loss of Symbiodiniaceae resulting from ocean warming, is currently one of the leading causes of reef deterioration. Corals lose their source of nourishment when their algae symbionts die, which typically […]

Corals

Related Post

  • BiotechToday
  • World

LIQA: a revolutionary method of quantifying isoform expression

bioxone June 23, 2021June 23, 2021

Saakshi Bangera, DY Patil School of Biotechnology and Bioinformatics RNA splicing is one of the most important processes of generating discrepancy in the transcriptome and is of utmost importance to humans. Errors in the regulation of RNA splicing lead to a wide range of genetic diseases, specifically caused by genetic mutations. RNA sequencing techniques have […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Indulgence of dominant primates in vocal communication!

bioxone August 1, 2021August 1, 2021

Avani Dave, BSc Life Sciences Background:  A “multiple levels of analysis” method has been proposed frequently in the effort to explain the evolution of human and non-human primates’ behaviour. In practice, most studies focus on a single level of analysis, despite the fact that such an approach needs investigations to cover multiple levels of a […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

A genotypic variant rs2666433 of microRNA-34a, as a novel biomarker and future for genetic risk profiling in colorectal cancer

bioxone October 12, 2020October 11, 2020

Chitra Roy, University of Calcutta MicroRNA is a non-protein-coding RNA molecule about 18-22 nucleotides long which post-transcriptionally regulates various gene expression through genetic and epigenetic mechanisms. They have several target genes on mRNA and the complementarity of microRNA-mRNA is the basis of gene silencing either by inhibiting the translation process or by directly degrading the […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy